Related Experiment Videos

Is the prevalence of coronary heart disease falling in British men?

F C Lampe1, R W Morris, P H Whincup

  • 1Cardiovascular Research Unit, Department of Primary Care and Population Sciences, Royal Free and UCL Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK. f.lampe@pcps.ucl.ac.uk

Insights

Middle-aged British men experience fewer angina symptoms, but diagnosed coronary heart disease (CHD) prevalence remains stable. Declining CHD event rates do not reduce the ongoing need for secondary prevention in this population.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Coronary heart disease (CHD) is a major public health concern, particularly in middle-aged men.
  • Understanding long-term trends in CHD event rates and prevalence is crucial for effective public health strategies.
  • Previous decades have seen significant efforts in CHD prevention and management.

Purpose of the Study:

  • To investigate the relationship between long-term trends in acute coronary heart disease (CHD) event rates and the burden of prevalent CHD in British men.
  • To analyze changes in angina symptoms and diagnosed CHD history over time.
  • To compare trends in CHD prevalence with CHD event rates.

Main Methods:

  • A longitudinal cohort study involving 7735 British men, aged 40-59 at baseline (1978-80).
  • Data on angina symptoms and diagnosed CHD history were collected via questionnaire in 1978-80, 1983-85, 1992, and 1996.
  • New major CHD events (fatal and non-fatal) were tracked using national registers and general practice records.

Main Results:

  • A significant decline in the prevalence of current angina symptoms was observed between 1978 and 1996 (-1.8% annually).
  • No significant trend was found in the prevalence of a history of diagnosed CHD (0.1% annually).
  • CHD mortality rates decreased substantially (-4.1% annually), alongside reductions in non-fatal myocardial infarction and overall major CHD events.

Conclusions:

  • Middle-aged British men report fewer angina symptoms but maintain a similar prevalence of diagnosed coronary heart disease.
  • Despite falling rates of new CHD events and symptom prevalence, the necessity for secondary prevention in men with established CHD remains high.
  • These findings underscore the persistent burden of established CHD and the continued importance of secondary prevention strategies.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...